{"id":"W4405044256","doi":"10.1182/blood-2024-194610","title":"Efficacy and Safety of Pozelimab Plus Cemdisiran Vs Ravulizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria Who Are Naïve to Complement Inhibition","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Internal medicine; Eculizumab; Clinical endpoint; Gastroenterology; Interim analysis; Neutropenia; Clinical trial; Surgery; Antibody; Immunology; Chemotherapy; Complement system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001166745,0.0006615045,0.001919401,0.0002957729,0.000273063,0.0008810196,0.0004991936,0.0008309266,0.002749854],"category_scores_gemma":[0.001245646,0.0003333804,0.001467374,0.0002544253,0.0005497233,0.0008313214,0.0002379266,0.002168446,0.000540199],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008022162,"about_ca_system_score_gemma":0.0009285866,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004869286,"about_ca_topic_score_gemma":0.001492859,"domain_scores_codex":[0.9996326,0.0001451147,0.00002718979,0.00007049294,0.00003238875,0.00009224497],"domain_scores_gemma":[0.9992366,0.0002175864,0.0001506855,0.00003784262,0.00002927636,0.0003279827],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.906161,0.009714092,0.004599039,0.000469858,0.0008096374,0.0001574168,0.000112527,0.0008671322,0.01097044,0.0001250224,0.001234388,0.06477944],"study_design_scores_gemma":[0.5009125,0.4671643,0.02355619,0.00007857254,0.001482844,0.0003338424,0.00008594502,0.001760269,0.002346993,0.0002595374,0.001978811,0.00004016998],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946859,0.00342077,0.0001372414,0.0002638173,0.0001052969,0.0002461904,0.000246324,0.00002990356,0.0008645256],"genre_scores_gemma":[0.9973704,0.0008221312,0.0003036012,0.0002897787,0.0001408932,0.0002822904,0.000324998,0.000004954214,0.0004609198],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002749854,"threshold_uncertainty_score":0.009199202,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00829089565356706,"score_gpt":0.2266210162547149,"score_spread":0.2183301206011479,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}